Delivery Order SPE2DR25D3501-SPE2DR26FM2EM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml quantity, valued at $2,638.27. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,293.41 on November 25, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml quantities. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is a child...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $4,552.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml), valued at $1,234.22. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of December 31, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in 150ml quantities, with a ceiling value of $5,042.70 and a firm fixed price contract type. This award was not set aside for small business or other designated groups and represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle. The place of performance is identified as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 120 mL quantities, with a ceiling value of $1,862.76 and a firm fixed price contract type. This delivery order represents a non-set-aside, competitively awarded procurement and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,971.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,158.71 to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 150 mL quantities. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,626.04 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price contract was issued on October 21, 2025, with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM2EMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Quillivant XR 25 mg/5 mL suspension in a 180 mL quantity, valued at $4,878.91 with a firm fixed-price structure. This non-set-aside award was issued under a competitive process and is performable in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. The contract represents a task order execution under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, specifically supporting the Defense Logistics Agency's medical supply chain requirements for military healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle for this delivery order. The parent company maintains a comprehensive prime IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031, enabling the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award demonstrates AmerisourceBergen's continued role as a critical vendor in the federal pharmaceutical supply chain, delivering essential medications across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/11/26 |